Deals
Axa's IPO Flop Shows Investor Dismay at Insurer's Strategy
- Deal prices well short of price range to raise $2.75 billion
- IPO seen underscoring concern at $15.3 billion XL Group buyout
This article is for subscribers only.
Investors gave a resounding thumbs-down to the partial spinoff of Axa SA’s U.S. business, dealing a blow to boss Thomas Buberl’s strategy for the French insurer.
The sale of part of its U.S. operations raised almost $1 billion less than the company had hoped for, amid concern among shareholders at the $15.3 billion takeover of XL Group Ltd. which the IPO will help finance.